Go to deals
Healthcare | TMT

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

May 2024 — Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Founded in 1989, Medis Medical Imaging Systems B.V. provides high-quality quantitative analysis solutions for cardiovascular imaging to the medical community. Medis’ software is internationally appreciated due to its ease of use and clinical outcomes for patients. The company continuously focuses on creating, researching and innovating towards clinically relevant software solutions in the field of cardiovascular imaging.

Our role in the transaction

Oaklins’ team in the Netherlands acted as the exclusive strategic advisor to the shareholders and management of Medis Medical Imaging Systems B.V.

“We are delighted to be taking this next step with GE HealthCare, a fellow leader in the interventional cardiology domain. Building on Medis QFR’s decade of AI research, customer-focused product development, clinical evidence generation and business development, we are excited to be able to further accelerate our efforts around Medis QFR to enable more hospitals and clinicians to apply physiology in day-to-day interventional practice as part of clinical care best practices, making this technology more accessible and available to patients than ever before.”

Maya Barley

CEO, Medis Medical Imaging Systems B.V.

Talk to the deal team

Martijn de Win

Director
Amsterdam, Netherlands
Oaklins Netherlands

Robert Boersma

Senior Advisor
Amsterdam, Netherlands
Oaklins Netherlands

Robbert Bon

Senior Associate
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Private Equity | Healthcare

Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy

Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.

Learn more
itemedical has been acquired by Halma
Healthcare | TMT

itemedical has been acquired by Halma

itemedical, a Netherlands-based provider of digital platforms that integrate real-time patient data and alarms from a wide range of medical devices to support clinical decision-making and workflow efficiency in hospitals, has been acquired by Halma plc, a global group of life-saving technology companies. The acquisition represents a milestone in itemedical’s development and provides a platform for its next phase of growth. By joining Halma’s healthcare sector as a business unit of Halma subsidiary Static Systems Group (SSG), itemedical will strengthen its position as a provider of digital hospital workflow solutions, benefiting from access to a global network of technology businesses, resources to accelerate innovation and opportunities to expand its international footprint.

Learn more
Evoke Creative has been acquired by Steliau Technology
TMT

Evoke Creative has been acquired by Steliau Technology

Private equity firm BGF has sold Evoke Creative Ltd., an international provider of interactive digital solutions, to Steliau Technology, a company backed by Astorg Partners. Evoke will continue to operate as an independent brand while benefiting from the wider group’s support to accelerate international expansion, increase product innovation and strengthen its position in key vertical markets.

Learn more